SARS-CoV-2 Vaccine
Showing 1 - 25 of >10,000
SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,
Not yet recruiting
- SARS-CoV-2 Infection
- +4 more
- Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)
Recruiting
- COVID-19
- the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
-
Guangzhou, Guangzhou, ChinaThe Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- Saline
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease
Not yet recruiting
- Metabolic Associated Fatty Liver Disease
- Recombinant protein vaccine and adenovirus vector vaccine
- (no location specified)
Feb 12, 2023
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in
Active, not recruiting
- SARS-CoV-2 RNA Vaccines
- HIV Infection
- SARS-CoV-2 Vaccine
-
Sevilla, SpainVirgen del Rocio University Hospital
Dec 1, 2022
COVID-19 Trial in Shang Qiu (low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell), high-dose Recombinant SARS-CoV-2 Vaccine (CHO
Active, not recruiting
- COVID-19
- low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
- +2 more
-
Shang Qiu, He Nan, ChinaNing ling Center for Disease Control and Prevention
Jan 31, 2023
COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)
Active, not recruiting
- COVID-19
- Vaccine Reaction
- LYB001
- CoronaVac
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023
Vaccine Reaction Trial in Venice-Lido (blood sample collection)
Active, not recruiting
- Vaccine Reaction
- blood sample collection
-
Venice-Lido, ItalyIRCCS San Camillo
Aug 24, 2022
SARS-CoV-2, Safety, Immunotoxicity Trial in Wuhan (one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity,
Not yet recruiting
- SARS-CoV-2
- +2 more
- one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)
- +3 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Aug 9, 2022
COVID-19 Trial in Nanjing (Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell))
Completed
- COVID-19
- Recombinant SARS-CoV-2 Ad5 vectored vaccine
- Inactive SARS-CoV-2 vaccine (Vero cell)
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Mar 28, 2022
COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- QTP104 1ug
- +2 more
-
Seoul, Korea, Republic of
- +1 more
May 24, 2023
COVID-19 Trial in Shijiazhuang (SARS-CoV-2 Inactivated Vaccine, Placebo)
Completed
- COVID-19
- SARS-CoV-2 Inactivated Vaccine
- Placebo
-
Shijiazhuang, Hebei, ChinaZanhuang county Center for Disease Control and Prevention
Aug 10, 2022
Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic
Not yet recruiting
- Chronic Lymphocytic Leukemia
- COVID-19 Infection
- Biospecimen Collection
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
COVID-19 Trial in Wuhan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, ZF2001)
Active, not recruiting
- COVID-19
- Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
- ZF2001
-
Wuhan, Hubei, ChinaHubei Provincial Center for Disease Control and Prevention
Jan 12, 2023
COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)
Active, not recruiting
- COVID-19
- LYB002V14
- +2 more
-
Chengdu, Sichuan, ChinaAffiliated Hospital of North Sichuan MedicalCollege
Jun 29, 2023
COVID-19 Pneumonia, COVID-19 Trial in Abu Dhabi (SARS-CoV-2 Vaccine (Vero Cell), Inactivated)
Recruiting
- COVID-19 Pneumonia
- COVID-19
- SARS-CoV-2 Vaccine (Vero Cell), Inactivated
-
Abu Dhabi, United Arab EmiratesSheikh Khalifa Medical City, SEHA
Jul 10, 2022
Coadministration of Influenza Vaccination With Booster Dose of
Completed
- Co-administration of COVID-19 and Influenza Vaccines
- COMIRNATY
-
Roma, RM, ItalyFondazione Policlinico Gemelli
Mar 10, 2023
Covid19 Trial in Cypress (VXA-CoV2-1)
Completed
- Covid19
- VXA-CoV2-1
-
Cypress, CaliforniaWCCT
Jan 17, 2023
Covid-19 Vaccine Trial (PIKA COVID-19 vaccine)
Not yet recruiting
- Covid-19 Vaccine
- PIKA COVID-19 vaccine
- (no location specified)
Jul 17, 2022
SARS-CoV-2 Trial in Islamabad (LVRNA009, CoronaVac®)
Not yet recruiting
- SARS-CoV-2
- LVRNA009
- CoronaVac®
-
Islamabad, PakistanClinical Trial Unit, National Institute of Health
Jun 22, 2022
COVID-19 Trial in Xuzhou (Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule, Two
Completed
- COVID-19
- Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule
- +11 more
-
Xuzhou, Jiangsu, ChinaSuining County Center for Disease Control and Prevention
Feb 22, 2022
SARS-CoV2 Infection Trial in Renton (HDT-301)
Active, not recruiting
- SARS-CoV2 Infection
- HDT-301
-
Renton, WashingtonRainier Clinical Research
Jan 16, 2023
Effectiveness of the COVID-19 Inactivated Vaccine
Active, not recruiting
- COVID-19
- SARS-CoV-2 vaccine (Vero cell) inactivated
-
Bandung, Indonesia
- +3 more
Sep 4, 2022
Antibody Detection of Vaccine-Induced Secretory Effects
Active, not recruiting
- Covid19
- +3 more
- SARS-CoV-2 vaccine
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 18, 2022